TickerFactsScreenerDevelopers

Lyell Immunopharma, Inc. (LYEL) — Shares Outstanding

Annual figures by fiscal year, from SEC filings.

2019: 5.4K2020: 13.26M2021: 135.92M2022: 247.08M2023: 12.55M2024: 13.07M2025: 17.09M17.09M
2019Shares Outstanding (shares)2025
Fiscal YearShares OutstandingChange YoY
202517.09M+30.7%
202413.07M+4.2%
202312.55M-94.9%
2022247.08M+81.8%
2021135.92M+925.2%
202013.26M+244107.0%
20195.4K—